Pharmaceutical and Medical Device
King & Spalding’s Pharmaceutical & Medical Device practice is consistently recognized as among the best in the nation. Our knowledge of the industry, combined with our broad capabilities and a deep bench of first-chair trial attorneys, allow us to handle any aspect of drug and device litigation, from early case assessment, through discovery, and on to trial and exit strategies.
June 9, 2025
MultiPlan Algorithmic Pricing Antitrust Claims Survive Motion to Dismiss
June 5, 2025
Administrative, Congressional, and State Interest Signal a Potential Breakthrough Moment for Psychedelics
June 4, 2025
FDA Issues Two Guidances For the Device Q-Sub Process
May 12, 2025
Former GE Healthcare, Fresenius Litigation & Compliance Leader Pat Murphy Joins King & Spalding in Washington, D.C.
April 9, 2025
King & Spalding Secures Another Victory for Boehringer Ingelheim in Zantac-Related Retrial
March 31, 2025
King & Spalding Secures Victory for The American Clinical Laboratory Association Challenging a Final Rule Issued by the FDA
March 26, 2025
Heartflow Completes Convertible Notes Financing